These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32681646)

  • 1. Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.
    Scheurer J; Reisser T; Leithäuser F; Messmann JJ; Holzmann K; Debatin KM; Strauss G
    Clin Exp Immunol; 2020 Dec; 202(3):407-422. PubMed ID: 32681646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-Versus-Host Disease Prevention by
    Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
    Front Immunol; 2021; 12():754316. PubMed ID: 34721430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
    Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
    Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
    Foley JE; Jung U; Miera A; Borenstein T; Mariotti J; Eckhaus M; Bierer BE; Fowler DH
    J Immunol; 2005 Nov; 175(9):5732-43. PubMed ID: 16237064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.
    Messmann JJ; Reisser T; Leithäuser F; Lutz MB; Debatin KM; Strauss G
    Blood; 2015 Aug; 126(9):1138-48. PubMed ID: 26185131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
    Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow.
    Blazar BR; Taylor PA; Sehgal SN; Vallera DA
    Blood; 1994 Jan; 83(2):600-9. PubMed ID: 8286755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis.
    Ehx G; Ritacco C; Hannon M; Dubois S; Delens L; Willems E; Servais S; Drion P; Beguin Y; Baron F
    Am J Transplant; 2021 Aug; 21(8):2662-2674. PubMed ID: 33512760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Nano-Micelle Ophthalmic Solution Reduces Corneal Allograft Rejection by Potentiating Myeloid-Derived Suppressor Cells' Function.
    Wei C; Wang Y; Ma L; Wang X; Chi H; Zhang S; Liu T; Li Z; Xiang D; Dong Y; Wu X; Shi W; Gao H
    Front Immunol; 2018; 9():2283. PubMed ID: 30349533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.
    Nakamura T; Nakao T; Yoshimura N; Ashihara E
    Am J Transplant; 2015 Sep; 15(9):2364-77. PubMed ID: 25943210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
    Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA
    J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation.
    Charak BS; Agah R; Mazumder A
    Blood; 1992 Jul; 80(1):179-84. PubMed ID: 1611084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
    Zhang J; Chen HM; Ma G; Zhou Z; Raulet D; Rivera AL; Chen SH; Pan PY
    Leukemia; 2019 Aug; 33(8):2078-2089. PubMed ID: 30737483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
    Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.
    Schultz KR; Bader S; Paquet J; Li W
    Blood; 1995 Dec; 86(11):4344-52. PubMed ID: 7492796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.
    Wu T; Zhao Y; Wang H; Li Y; Shao L; Wang R; Lu J; Yang Z; Wang J; Zhao Y
    Sci Rep; 2016 Feb; 6():20250. PubMed ID: 26833095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.